MARKET

LMAT

LMAT

Lemaitre Vasculr
NASDAQ
50.93
+0.25
+0.49%
Opening 10:55 10/03 EDT
OPEN
51.28
PREV CLOSE
50.68
HIGH
51.39
LOW
48.44
VOLUME
6.69K
TURNOVER
230.75K
52 WEEK HIGH
56.47
52 WEEK LOW
38.12
MARKET CAP
1.12B
P/E (TTM)
50.56
1D
5D
1M
3M
1Y
5Y
Those who invested in LeMaitre Vascular (NASDAQ:LMAT) three years ago are up 65%
One simple way to benefit from the stock market is to buy an index fund. But if you buy good businesses at attractive...
Simply Wall St. · 4d ago
BRIEF-Lemaitre Vascular Says Board Appointed Martha Shadan As Director
BRIEF-Lemaitre Vascular Says Board Appointed Martha Shadan As Director
Reuters · 09/23 13:23
Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Today we will run through one way of estimating the intrinsic value of LeMaitre Vascular, Inc. ( NASDAQ:LMAT ) by...
Simply Wall St. · 09/03 14:00
LeMaitre Vascular goes ex dividend tomorrow
LeMaitre Vascular (NASDAQ:LMAT) has declared <a href="https://se...
Seekingalpha · 08/23 16:50
Insider Sell: Lemaitre Vascular
Insider Sell: Lemaitre Vascular
MT Newswires · 08/16 07:24
ZBH vs. LMAT: Which Stock Should Value Investors Buy Now?
ZBH vs. LMAT: Which Stock Is the Better Value Option?
Zacks · 08/05 15:40
LeMaitre to Present at the Canaccord Genuity 42nd Annual Growth Conference
BURLINGTON, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference on Thursday, August 11, 2022, at 12:...
GlobeNewswire · 08/01 20:25
LeMaitre Vascular Posts Lower Q2 Adjusted Earnings, Sales Rise; Adjusts 2022 Outlook
LeMaitre Vascular Posts Lower Q2 Adjusted Earnings, Sales Rise; Adjusts 2022 Outlook
MT Newswires · 07/29 10:22
More
About LMAT
LeMaitre Vascular, Inc. is a provider of medical devices and human tissue cryopreservation services, which are used in the treatment of peripheral vascular disease, end-stage renal disease and to a lesser extent cardiovascular disease. The Company develops, manufactures and markets vascular devices to address the needs of vascular surgeons, and to a lesser degree, other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. It sold its principal product in the United States, Europe, the United Kingdom, Canada and Asia Pacific. The Company sales its products and services primarily through a direct sales force. Its products and services offering includes Allografts, Angioscopes, Balloon Catheters for Embolectomy and Thrombectomy, Balloon Catheters for Occlusion and Perfusion, Bovine Grafts, Vascular and Cardiac Patches, Carotid Shunts, Closure Systems, Ovine Vascular Grafts, Polyester Vascular Grafts, ePTFE Vascular Grafts, Radiopaque Tape, and Valvulotomes.

Webull offers kinds of LeMaitre Vascular Inc stock information, including NASDAQ:LMAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LMAT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LMAT stock methods without spending real money on the virtual paper trading platform.